Technology Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology to Deliver More… AIT News Desk Nov 21, 2022 Merck, a leading science and technology company, shared updates on the company’s healthcare research and development strategy, aimed at doubling…
Financial Services AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development AIT News Desk Dec 13, 2020 Greater scientific presence in immunology by adding Alexion's innovative complement-technology platforms and strong pipeline AstraZeneca and Alexion…